Rel/NF-kappaB Family Member RelA Regulates NK1.1- to NK1.1+ Transition As Well As IL-15-induced Expansion of NKT Cells
Overview
Authors
Affiliations
Development of NKT cells was shown to depend on lymphotoxin (LT) and IL-15 signaling pathways as well as on cytokine receptor common gamma chain. After positive selection, NKT-cell precursors transit through progressive maturation stages including proliferative expansion within the NK1.1(-) window. The transcription factors that integrate different signaling pathways into different stages of NKT-cell development are not well characterized. Here, we show that the Rel/NF-kappaB family member RelA regulates the NK1.1(-) to NK1.1(+) transition during NKT-cell development. RelA is also required for both IL-15- and IL-7-induced proliferation of CD44(hi)NK1.1(-) NKT-cell precursors. Activation of the invariant NKT-cell receptor induces both IL-15 receptor alpha and gamma chains' expression in an NF-kappaB-dependent manner, suggesting a molecular mechanism by which NF-kappaB regulates NKT-cell development. NF-kappaB also regulates TCR-induced expression of LT-alpha and LT-beta within NKT cells. In contrast to previous reports, however, we show that LT signaling is dispensable for thymic NKT-cell development but is essential for their colonization of peripheral organs such as liver.
New insights into iNKT cells and their roles in liver diseases.
Gu X, Chu Q, Ma X, Wang J, Chen C, Guan J Front Immunol. 2022; 13:1035950.
PMID: 36389715 PMC: 9643775. DOI: 10.3389/fimmu.2022.1035950.
Zhou Q, Doherty J, Akk A, Springer L, Fan P, Spasojevic I Nanomaterials (Basel). 2022; 12(3).
PMID: 35159680 PMC: 8839776. DOI: 10.3390/nano12030336.
Tersteegen A, Sorg U, Virgen-Slane R, Helle M, Petzsch P, Dunay I Infect Immun. 2021; 89(6).
PMID: 33753412 PMC: 8316152. DOI: 10.1128/IAI.00026-21.
Wang J, Li K, Zhang X, Li G, Liu T, Wu X Front Cell Dev Biol. 2021; 8:619220.
PMID: 33585457 PMC: 7874147. DOI: 10.3389/fcell.2020.619220.
Regulation of PD-L1 Expression by NF-κB in Cancer.
Antonangeli F, Natalini A, Garassino M, Sica A, Santoni A, Di Rosa F Front Immunol. 2020; 11:584626.
PMID: 33324403 PMC: 7724774. DOI: 10.3389/fimmu.2020.584626.